NEW! DEA MATE ACT:
Beginning with DEA initial registrations or renewals starting June 27, 2023, all DEA-registered practitioners (with the exception of DVM-only license holders) are required to complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders.
Mandatory Subjects:
MDs are required 150 hours every three years, 1 hour of which must be in the area of medical ethics, and a minimum of 3 hours of which must be in the area of pain and symptom management. At least 1 of the 3 required hours in pain and symptom management must include controlled substances prescribing.
DOs are required 150 hours every three years, 1 hour of which must be in the area of medical ethics, and a minimum of 3 hours of which must be in the area of pain and symptom management. At least 1 of the 3 required hours in pain and symptom management must include controlled substances prescribing. A maximum 110 hours may be AMA PRA Category 1 Credit™.
NEW Beginning June 1, 2022, an applicant for licensure or registration must have completed a minimum of two (2) hours of implicit bias training within the 5 years immediately preceding issuance of the license or registration. For every renewal thereafter, in addition to completing any continuing education required for renewal, reregistration, or relicensure, an applicant must have completed a minimum of one (1) hour of implicit bias training for each year of the applicant's license or registration cycle. If otherwise permitted by the code and rules, this training may be used to satisfy other training or continuing education requirements. Instruction must be synchronous/interactive or asynchronous teleconference or webinar. (Per MI R 338.7004 eff 3/23/2023)
MDs and DOs have a one-time requirement of training in identifying victims of human trafficking. Licensees renewing in 2017 must complete training by 2020 renewal; licensees renewing in 2018 must complete by 2021 renewal; and, licensees renewing in 2019 must complete by 2022 renewal. Beginning in 2021, completion of the training is a requirement for initial licensure.
Beginning September 1, 2019, physicians seeking a controlled substance license, or who are licensed to prescribe or dispense controlled substances, must complete a one-time training in opioids and controlled substance awareness prior to being issued a controlled substance license.
Beginning with DEA initial registrations or renewals starting June 27, 2023, all DEA-registered practitioners (with the exception of DVM-only license holders) are required 8 hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder, one-time only.
Medical Directors of a Substance Use Disorder Service Program branch or mobile facility are required 30 hours of ACCME-approved continuing education, every three years. There is an initial requirement of 30 hours in addiction psychiatry or addiction medicine.
